ImageneBio, Inc. (IMA) stock
IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.81−0.09 (-2.31%)
Close on Nov 18, 2026Market cap $43.25MP/E –Yield –
ImageneBio free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
ImageneBio's free cash flow for the twelve months ending Dec 31, 2023 was -$80.16M. For fiscal 2023 it was -$80.16M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$80.16M | – |
| FY2022 | Dec 31, 2022 | -$75.54M | – |
| FY2021 | Dec 31, 2021 | -$62.01M | – |
| FY2020 | Dec 31, 2020 | -$38.59M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -$22.08M | – |
| Q3 FY2023 | Sep 30, 2023 | -$20.00M | – |
| Q2 FY2023 | Jun 30, 2023 | -$18.14M | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.94M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.89M | – |
| Q3 FY2022 | Sep 30, 2022 | -$18.35M | – |
| Q2 FY2022 | Jun 30, 2022 | -$19.49M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.82M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.92M | – |
| Q3 FY2021 | Sep 30, 2021 | -$18.17M | – |
| Q2 FY2021 | Jun 30, 2021 | -$15.91M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.01M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.22M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.67M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.71M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.99M | – |
See a number that looks wrong?